BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 29, 2026
Home » Authors » Tamra Sami

Articles by Tamra Sami

Australia's Telix forges global partnerships to harness power of radiopharmaceuticals

May 2, 2018
By Tamra Sami
PERTH, Australia – Following its IPO on Australia's Securities Exchange in November, Aussie radiopharma company Telix Pharmaceuticals Ltd. has been building up global partnerships to prepare for a commercial build-up of its "theranostic" radiopharmaceuticals.
Read More

Australia's Telix forges global partnerships to harness power of radiopharmaceuticals

May 1, 2018
By Tamra Sami

Aussie med techs get government funding boost to bridge investment gaps

April 27, 2018
By Tamra Sami

Australia's Telix forges global partnerships to harness power of radiopharmaceuticals

April 26, 2018
By Tamra Sami
PERTH, Australia – Following its IPO on Australia's Securities Exchange in November, Aussie radiopharma company Telix Pharmaceuticals Ltd. has been building up global partnerships to prepare for a commercial build-up of its "theranostic" radiopharmaceuticals.
Read More

Aussie biotechs to benefit from strategic intervention partnering program

April 25, 2018
By Tamra Sami
PERTH, Australia – Australia's Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) and Biopacific Partners have launched a new program that will work with small Australian biotechs to better prepare them for partnering with big pharma.
Read More

Avita's Recell spray-on-skin device meets primary endpoints in two pivotal trials

April 20, 2018
By Tamra Sami

Aussie biotechs to benefit from strategic intervention partnering program

April 19, 2018
By Tamra Sami
PERTH, Australia – Australia's Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) and Biopacific Partners have launched a new program that will work with small Australian biotechs to better prepare them for partnering with big pharma.
Read More

Australia's life sciences sector braces for battle over looming budget

April 18, 2018
By Tamra Sami
PERTH, Australia – Another battle is brewing over Australia's Research and Development Tax Incentive in the lead up to the annual Federal Budget that is released in early May.
Read More

Australian consumers and industry at odds over patient implant cards

April 17, 2018
By Tamra Sami

Australia's life sciences sector braces for budget battle

April 16, 2018
By Tamra Sami
Previous 1 2 … 212 213 214 215 216 217 218 219 220 … 236 237 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 29, 2026.
  • Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

    ENCALS 2026: From genetics to advancing strategies against ALS

    BioWorld Science
    Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
  • Subsense BCI platform

    Next wave of BCI firms builds on pioneers to tackle challenges

    BioWorld
    With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
  • Boehringer Ingelheim identifies new mGlu3 receptor agonists

    BioWorld Science
    Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
  • GT-02897 exerts efficacy in preclinical multiple myeloma

    BioWorld Science
    Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing